1-20 of 85
David J. Straus
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Two Decade Single Institution Experience Highlights Rare Survivors with Relapsed or Refractory Burkitt Lymphoma

Rabeya Molla, Ellin Berman, Philip Caron, Gerard Donnelly, Lorenzo Falchi, Paul A. Hamlin, Steven Horwitz, Andrew M. Intlekofer, William T. Johnson, Joseph G Jurcic, Anita Kumar, Jennifer Kimberly Lue, Alison Moskowitz, Colette Owens, Parastoo B Dahi, Maria Lia Palomba, Carol S. Portlock, Gilles Salles, Craig S Sauter, Santosha A. Vardhana, Gunjan L. Shah, David J. Straus, Anas Younes, Anas Younes, Andrew D. Zelenetz, Ariela Noy
Journal: Blood
Blood (2024) 144 (Supplement 1): 6520.
https://doi.org/10.1182/blood-2024-210617
Published: 2024
Journal Articles

Updated Analysis of Brentuximab Vedotin, Nivolumab, Doxorubicin, and Dacarbazine for Nonbulky, Early-Stage Classical Hodgkin Lymphoma

Jeremy S. Abramson, David J. Straus, Nancy L. Bartlett, John M. Burke, Ryan C. Lynch, Eva Domingo Domenech, Brian Hess, Steven Schuster, Yuliya Linhares, Rod Ramchandren, Mitul Gandhi, Harsh R. Shah, Wojciech Jurczak, Alessandro Re, Uwe Hahn, H. Miles Prince, Wenchuan Guo, Griffith Davis, Linda Ho, Christopher Yasenchak, Hun Ju Lee
Journal: Blood
Blood (2024) 144 (Supplement 1): 460.
https://doi.org/10.1182/blood-2024-200992
Published: 2024
Journal Articles

Devimistat Results in a Low Complete Remission Rate in Heavily Pre-Treated Burkitt Lymphoma

Raphael Steiner, Liana Nikolaenko, Swetha Kambhampati, Niloufer Khan, Ranjit Nair, Jeremy S. Abramson, Steven Horwitz, Matthew Matasar, Colette Owens, Ildefonso Ismael Rodriguez Rivera, David J. Straus, Timothy S Pardee, Sanjeev Luther, Win Su Thet, Shreya Vemuri, Ariela Noy
Journal: Blood
Blood (2024) 144 (Supplement 1): 1729.
https://doi.org/10.1182/blood-2024-202459
Published: 2024
Journal Articles

Sequential R-CHOP/(R)-ICE and Dose-Adjusted EPOCH-R Are Both Appropriate Frontline Treatments for Newly Diagnosed Primary Mediastinal B-Cell Lymphoma: Results of a Retrospective Analysis

Kurt S. Bantilan, Efrat Luttwak, Craig H. Moskowitz, Matthew Matasar, David J. Straus, Carol S. Portlock, Alison Moskowitz, Ariela Noy, Maria Lia Palomba, Steven Horwitz, Gilles Salles, Colette Owens, Pallawi Torka, Alexander P. Boardman, Kevin A. David, Zachary D. Epstein-Peterson, Anita Kumar, Philip Caron, Paola Ghione, Lorenzo Falchi, Jennifer K Lue, Raphael Steiner, Robert Stuver, Ahmet Dogan, Paul A. Hamlin, Andrew D. Zelenetz
Journal: Blood
Blood (2024) 144 (Supplement 1): 4485.
https://doi.org/10.1182/blood-2024-205803
Published: 2024
Journal Articles

Brentuximab Vedotin, Nivolumab, Doxorubicin, and Dacarbazine (AN+AD) for Early-Stage Classical Hodgkin Lymphoma (SGN35-027 Part C)

Jeremy S. Abramson, David J. Straus, Nancy L. Bartlett, John M. Burke, Ryan C Lynch, Eva Domingo Domenech, Brian Hess, Steven R. Schuster, Yuliya Linhares, Rod Ramchandren, Mitul Gandhi, Rex Mowat, Harsh Shah, Wojciech Jurczak, Alessandro Re, Uwe Hahn, H. Miles Prince, Wenchuan Guo, Linda Ho, Rose C. Beck, Christopher A. Yasenchak, Hun Ju Lee
Journal: Blood
Blood (2023) 142 (Supplement 1): 611.
https://doi.org/10.1182/blood-2023-172574
Published: 2023
Journal Articles

Brentuximab Vedotin Combined with Chemotherapy in Newly Diagnosed, Early-Stage, Unfavorable-Risk Hodgkin Lymphoma: Extended Follow-up with Evaluation of Baseline Metabolic Tumor Volume and PET2

Robert Stuver, Laure Michaud, Carla Casulo, Ranjana H. Advani, Elizabeth L. Budde, Paul M. Barr, Connie Lee Batlevi, Philip C Caron, Louis S. Constine, Savita Dandapani, Pamela Drullinsky, Jonathan W. Friedberg, Clare Grieve, Audrey Hamilton, Paul A. Hamlin, Richard Hoppe, Steven M. Horwitz, Niloufer Khan, Matthew J. Matasar, Ariela Noy, M.Lia Palomba, Heiko Schoder, David J. Straus, Shreya Vemuri, Joachim Yahalom, Joanna C. Yang, Anas Younes, Andrew D. Zelenetz, Craig H. Moskowitz, Anita Kumar, Alison J. Moskowitz
Journal: Blood
Blood (2022) 140 (Supplement 1): 1756–1758.
https://doi.org/10.1182/blood-2022-156382
Published: 2022
Journal Articles

Characterization of a Large Cohort of Patients with Nodal Marginal Zone Lymphoma Shows Prolonged Survival, Time-to-Treatment, and Time-to-Transformation

Robert Stuver, Esther Drill, David Qualls, Michelle Okwali, Connie Lee Batlevi, Philip C Caron, Zachary D. Epstein-Peterson, Lorenzo Falchi, Audrey Hamilton, Paul A. Hamlin, Steven M. Horwitz, Andrew M. Intlekofer, William T. Johnson, Niloufer Khan, Oscar B Lahoud, Jennifer Kimberly Lue, Matthew J. Matasar, Alison J. Moskowitz, Ariela Noy, M.Lia Palomba, Santosha Vardhana, Andrew D. Zelenetz, Gilles Salles, David J. Straus
Journal: Blood
Blood (2022) 140 (Supplement 1): 9380–9382.
https://doi.org/10.1182/blood-2022-156383
Published: 2022
Journal Articles

Brentuximab Vedotin, Nivolumab, Doxorubicin, and Dacarbazine (AN+AD) for Early Stage Classic Hodgkin Lymphoma: Interim Efficacy and Safety Results from the Single-Arm Phase 2 Study (SGN35-027 Part C)

Hun Ju Lee, Jeremy S. Abramson, Nancy L. Bartlett, John M. Burke, Ryan C. Lynch, Domingo Domenech Eva, Brian T. Hess, Steven R. Schuster, Yuliya Linhares, Rod Ramchandren, Mitul Gandhi, Rex Mowat, Harsh Shah, Giuseppe Rossi, Uwe H Hahn, Henry Miles Prince, Linda Ho, Wenchuan Guo, Christopher A. Yasenchak, David J. Straus
Journal: Blood
Blood (2022) 140 (Supplement 1): 9399–9401.
https://doi.org/10.1182/blood-2022-156576
Published: 2022
Journal Articles

Immune Signature of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin As Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma

Beatriz Wills, Nivetha Ganesan, Gunjan L. Shah, Phillip Wong, Kimon V. Argyropoulos, Filiz Sen, Ahmet Dogan, David J. Straus, Ariela Noy, Anita Kumar, Heiko Schoder, Laure Michaud, Maria Lia Palomba, Lorenzo Falchi, Oscar B Lahoud, Paul A. Hamlin, Joachim Yahalom, William T. Johnson, Andrew D. Zelenetz, Andrew M. Intlekofer, Colette Owens, Connie Lee Batlevi, Audrey Hamilton, Philip C Caron, Steven M. Horwitz, Natasha Galasso, Helen Hancock, Theresa Davey, Alayna Santarosa, Leslie Perez, Charisse Capadona, Brittney Munayirji, Matthew J. Matasar, Georgios Pongas, Ellie Casper, Gilles Salles, Craig H. Moskowitz, Santosha Vardhana, Alison J. Moskowitz
Journal: Blood
Blood (2022) 140 (Supplement 1): 9286–9288.
https://doi.org/10.1182/blood-2022-160206
Published: 2022
Journal Articles

Molecular Profiling across Lymphoma Subtypes Using MSK-Impact Next Generation Sequencing

Connie Lee Batlevi, Esther Drill, Michelle Okwali, Ryan Ptashkin, Philip C Caron, Zachary D. Epstein-Peterson, Lorenzo Falchi, Audrey Hamilton, Paul A. Hamlin, Steven M. Horwitz, Andrew M. Intlekofer, William T. Johnson, Niloufer Khan, Anita Kumar, Jennifer Kimberly Lue, Matthew J. Matasar, Alison J. Moskowitz, Ariela Noy, Colette Owens, Maria Lia Palomba, David J. Straus, Santosha Vardhana, Andrew D. Zelenetz, Maria E. Arcila, Ahmet Dogan, Venkatraman Seshan, Gilles Salles, Ahmet Zehir, Anas Younes
Journal: Blood
Blood (2022) 140 (Supplement 1): 9251–9253.
https://doi.org/10.1182/blood-2022-158783
Published: 2022
Journal Articles

Clinical Outcomes and CNS Relapse Risk in Patients with Primary Cutaneous DLBCL, Leg Type Treated in the Rituximab Era: Long-Term Follow-up of a Single-Center Experience

Lorenzo Falchi, Annie Qiu, Mark D. Ewalt, Connie Lee Batlevi, Philip C Caron, Paul A. Hamlin, Audrey Hamilton, Steven M. Horwitz, Erel Joffe, Niloufer Khan, Anita Kumar, Alison J. Moskowitz, Ariela Noy, Colette Owens, Maria Lia Palomba, David J. Straus, Gottfried von Keudell, Andrew D. Zelenetz, Ahmet Dogan, Klaus Busam, Patricia Myskowski, Joachim Yahalom, Gilles Salles, Matthew J. Matasar
Journal: Blood
Blood (2021) 138 (Supplement 1): 2513.
https://doi.org/10.1182/blood-2021-151994
Published: 2021
Journal Articles

Impact of Choice of Platinum-Based Salvage Therapy on CNS Relapse in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Michael J Buege, Phuong Dao, Raymond G Dematteo, Andréa LeVoir, Terry Pak, Connie Lee Batlevi, Audrey Hamilton, Paul A. Hamlin, Steven M. Horwitz, Erel Joffe, William T Johnson, Niloufer Khan, Anita Kumar, Christina Y. Lee, Matthew J. Matasar, Alison J. Moskowitz, Ariela Noy, Colette Owens, M. Lia Palomba, David J. Straus, Gottfried von Keudell, Andrew D. Zelenetz, Christian Grommes, Craig S. Sauter, Gilles Salles, Lorenzo Falchi
Journal: Blood
Blood (2021) 138 (Supplement 1): 2529.
https://doi.org/10.1182/blood-2021-147527
Published: 2021
Journal Articles

Favorable Outcomes of Patients with Limited-Stage Ocular Adnexal DLBCL Treated in the Rituximab Era: Long-Term Follow-up of a Single Center Experience

David Qualls, Connie Lee Batlevi, Philip C Caron, Audrey Hamilton, Paul A. Hamlin, Steven M. Horwitz, Erel Joffe, Niloufer Khan, Anita Kumar, Matthew J. Matasar, Alison J. Moskowitz, Ariela Noy, Colette Owens, M. Lia Palomba, David J. Straus, Gottfried von Keudell, Andrew D. Zelenetz, Michelle Okwali, Joachim Yahalom, Heiko Schöder, Ahmet Dogan, Gilles Salles, Lorenzo Falchi
Journal: Blood
Blood (2021) 138 (Supplement 1): 4578.
https://doi.org/10.1182/blood-2021-153171
Published: 2021
Journal Articles

Interim Efficacy Analysis of a Phase II Study Demonstrates Promising Activity of the Combination of Pembrolizumab (PEM) and Entinostat (ENT) in Relapsed and Refractory (R/R) Hodgkin Lymphoma (HL)

David J. Sermer, Santosha Vardhana, Erin Biggar, Alison J. Moskowitz, Erel Joffe, Niloufer Khan, David J. Straus, Anita Kumar, Andrew D. Zelenetz, Steven M. Horwitz, Ariela Noy, Connie Lee Batlevi, Audrey Hamilton, Colette Owens, Matthew J. Matasar, M. Lia Palomba, Christina Y. Lee, Lorenzo Falchi, William T. Johnson, Heiko Schoder, Ahmet Dogan, Tira Bunyaviroch, Venkatraman Seshan, Gilles Salles, Anas Younes, Gottfried von Keudell
Journal: Blood
Blood (2021) 138 (Supplement 1): 2447.
https://doi.org/10.1182/blood-2021-154226
Published: 2021
Journal Articles

Quantitative Change in Metabolic Tumor Volume May Assist in Distinguishing between Pseudoprogressors and Responders in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma Treated with PD-1 Blockade

Beatriz Wills, Laure Michaud, Heiko Schöder, Nivetha Ganesan, Craig H. Moskowitz, David J. Straus, Lorenzo Falchi, Matthew J. Matasar, Andrew D. Zelenetz, Erel Joffe, Gottfried von Keudell, Connie Lee Batlevi, Audrey Hamilton, Philip C Caron, Ariela Noy, Gilles Salles, Alison J. Moskowitz
Journal: Blood
Blood (2021) 138 (Supplement 1): 1402.
https://doi.org/10.1182/blood-2021-153383
Published: 2021
Journal Articles

Complete Remission with Devimistat (CPI-613) in Refractory Burkitt Lymphoma

Liana Nikolaenko, Timothy Pardee, Raphel Steiner, Jeremy S. Abramson, Steven M. Horwitz, Matthew J. Matasar, Colette Owens, Ildefonso Rodriguez-Rivera, David J. Straus, Sanjeev Luther, Ariela Noy
Journal: Blood
Blood (2021) 138 (Supplement 1): 4555.
https://doi.org/10.1182/blood-2021-153662
Published: 2021
Journal Articles

A Phase 2 Study Evaluating the Addition of Ublituximab and Umbralisib (U2) to Ibrutinib in Patients with Chronic Lymphocytic Leukemia (CLL): A Minimal Residual Disease (MRD)-Driven, Time-Limited Approach

Lindsey E. Roeker, Lori A. Leslie, Jake D. Soumerai, Victoria Falco, Gail Panton, Andrew D. Zelenetz, Lorenzo Falchi, Jae H Park, Camila Pena-Velasquez, Sonia Lebowitz, Kristen Battiato, Carissa Laudati, Meghan C. Thompson, David J. Straus, Yehudit Fox, Elizabeth McCarthy, Sabrina Kdiry, Rosalba Martignetti, Hari P. Miskin, Peter Sportelli, Anthony R. Mato
Journal: Blood
Blood (2021) 138 (Supplement 1): 395.
https://doi.org/10.1182/blood-2021-146999
Published: 2021
Journal Articles

Favorable Outcomes Among Patients with T-Cell/Histiocyte-Rich Large B-Cell Lymphoma Treated with Higher-Intensity Therapy in the Rituximab Era

Edith Tama Robin, MD, Esther Drill, DrPH, Connie Lee Batlevi, MDPhD, Philip Caron, MD PhD, Lorenzo Falchi, MD, Audrey Hamilton, MD, Paul A. Hamlin, MD, Steven M. Horwitz, MD, Andrew M. Intlekofer, MD PhD, Erel Joffe, MD MSc, Anita Kumar, MD, Matthew J Matasar, MD, Ariela Noy, MD, Colette Owens, MD, Maria Lia Palomba, MD, Ildefonso Rodriguez-Rivera, MD, David J. Straus, MD, Santosha Vardhana, MD PhD, Gottfried R. von Keudell, MD PhD, Andrew D Zelenetz, MD PhD, Craig H. Moskowitz, MD, Alison J. Moskowitz, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 36–38.
https://doi.org/10.1182/blood-2020-136489
Published: 2020
Journal Articles

IVAC +/- R for Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas: Real-World Experience in the Modern Era

Michael J Buege, PharmD, Phuong H Dao, PharmD, Esther Drill, DrPH, Andréa C LeVoir, PharmD, Terry Pak, PharmD, Tim J Peterson, PharmD, David J. Straus, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 10.
https://doi.org/10.1182/blood-2020-134607
Published: 2020
Journal Articles

Brentuximab Vedotin with Chemotherapy for Patients with Previously Untreated, Stage III/IV Classical Hodgkin Lymphoma: 5-Year Update of the ECHELON-1 Study

David J. Straus, MD, Monika Dlugosz-Danecka, MD PhD, Joseph M. Connors, MD, Árpád Illés, MD PhD, Marco Picardi, MD, Ewa Lech-Marańda, MD PhD, Tatyana Feldman, Piotr Smolewski, MD PhD, Kerry J. Savage, MDMSc, Nancy L. Bartlett, MD, Jan Walewski, MD, Radhakrishnan Ramchandren, MD, Pier Luigi Zinzani, MD, Martin Hutchings, MD PhD, Javier Munoz, MD, Won Seog Kim, MD PhD, Ranjana Advani, MD, Stephen M. Ansell, MD PhD, Anas Younes, Andrea Gallamini, Rachael Liu, PhD, Meredith Little, MPH, Keenan Fenton, Michelle A. Fanale, MD, John A. Radford, MD FMedSci
Journal: Blood
Blood (2020) 136 (Supplement 1): 26–28.
https://doi.org/10.1182/blood-2020-137089
Published: 2020